Teva and Apotex prevail in sleep drug dispute

11-05-2023

Muireann Bolger

Teva and Apotex prevail in sleep drug dispute

Ralf Liebhold / Shutterstock.com

The dispute centred on a treatment that helps people adjust their circadian rhythm | Path now clear for generic drug makers to unveil biosimilar versions of the drug.


Teva, Apotex, Hetlioz, Non-24, patents

LSIPR